Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philippe Damier

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Neuroreport|April 20, 2004
Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's diseaseVincent Paillé, Philippe Brachet, Philippe Damier
International Review of Neurobiology|September 13, 2011
Surgery for tardive dyskinesiaStéphane Thobois, Alice Poisson, Philippe Damier
Frontiers in Cellular Neuroscience|May 6, 2016
Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn SeizuresYehezkel Ben-Ari, Philippe Damier, Eric Lemonnier
Clinical Neuropharmacology|January 13, 2016
Bumetanide to Treat Parkinson Disease: A Report of 4 CasesPhilippe Damier, Constance Hammond, Yeheskel Ben-Ari
BMJ Case Reports|September 27, 2012
Continuous buccolingual masticatory dyskinesia in Parkinson's diseaseClaire Meyniel, Pascal Derkinderen, Bernard Giumelli, et al.
Stereotactic and Functional Neurosurgery|April 19, 2008
Does dopamine still have a leading role in advanced Parkinson's disease after subthalamic stimulation?Mazen Jabre, George Nohra, Philippe Damier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesiasVincent Paillé, Vincent Henry, Laurent Lescaudron, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamineVincent Henry, Vincent Paillé, Faustine Lelan, et al.
Brain Communications|September 21, 2023
Response to: increased prevalence of normal pressure hydrocephalus in both variants of frontotemporal dementia: a 10-year retrospective studyAdrien de Guilhem de Lataillade, Philippe Damier, Hélène Pouclet-Courtemanche
Neurophysiologie Clinique = Clinical Neurophysiology|November 11, 2020
The value of non-invasive brain stimulation techniques in treating focal dystoniaJean-Pascal Lefaucheur, Philippe Damier, Julien Nizard, et al.
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Neuroreport|April 20, 2004
Role of nigral lesion in the genesis of dyskinesias in a rat model of Parkinson's diseaseVincent Paillé, Philippe Brachet, Philippe Damier
International Review of Neurobiology|September 13, 2011
Surgery for tardive dyskinesiaStéphane Thobois, Alice Poisson, Philippe Damier
Frontiers in Cellular Neuroscience|May 6, 2016
Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn SeizuresYehezkel Ben-Ari, Philippe Damier, Eric Lemonnier
Clinical Neuropharmacology|January 13, 2016
Bumetanide to Treat Parkinson Disease: A Report of 4 CasesPhilippe Damier, Constance Hammond, Yeheskel Ben-Ari
BMJ Case Reports|September 27, 2012
Continuous buccolingual masticatory dyskinesia in Parkinson's diseaseClaire Meyniel, Pascal Derkinderen, Bernard Giumelli, et al.
Stereotactic and Functional Neurosurgery|April 19, 2008
Does dopamine still have a leading role in advanced Parkinson's disease after subthalamic stimulation?Mazen Jabre, George Nohra, Philippe Damier, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|January 19, 2007
Rat model of Parkinson's disease with bilateral motor abnormalities, reversible with levodopa, and dyskinesiasVincent Paillé, Vincent Henry, Laurent Lescaudron, et al.
Journal of Neuropathology and Experimental Neurology|November 18, 2009
Kinetics of microglial activation and degeneration of dopamine-containing neurons in a rat model of Parkinson disease induced by 6-hydroxydopamineVincent Henry, Vincent Paillé, Faustine Lelan, et al.
Brain Communications|September 21, 2023
Response to: increased prevalence of normal pressure hydrocephalus in both variants of frontotemporal dementia: a 10-year retrospective studyAdrien de Guilhem de Lataillade, Philippe Damier, Hélène Pouclet-Courtemanche
Neurophysiologie Clinique = Clinical Neurophysiology|November 11, 2020
The value of non-invasive brain stimulation techniques in treating focal dystoniaJean-Pascal Lefaucheur, Philippe Damier, Julien Nizard, et al.
Pageof 11